Experience with Cefuroxime in 190 Patients with Severe Respiratory Infections
作者:
A. Pines,
H. Raafat,
M.R.K. Kennedy,
B.M. Mullinger,
期刊:
Chemotherapy
(Karger Available online 1980)
卷期:
Volume 26,
issue 3
页码: 212-217
ISSN:0009-3157
年代: 1980
DOI:10.1159/000237907
出版商: S. Karger AG
关键词: Cefuroxime;Cephalosporins;Treatment;Chronic bronchitis;Pneumonia;Bronchiectasis
数据来源: Karger
摘要:
Cefuroxime is a very effective agent for the treatment of severe purulent respiratory infections. 190 patients with purulent exacerbations of bronchitis or bronchiectasis, pneumonia or secondarily infected lung cancer received 2.25–3.0 g cefuroxime daily for an average of 9 days. A good clinical response was seen in 91% of 184 assessable patients. A remarkable improvement in sputum purulence was observed and side-effects to cefuroxime were minima
点击下载:
PDF
(1604KB)
返 回